首页
>
期刊首页
>
医学评论(英文)
>
2025年6期
>
Interplay between aging and metabolic diseases:from molecular mechanisms to therapeutic horizons
Interplay between aging and metabolic diseases:from molecular mechanisms to therapeutic horizons
摘要
Aging and metabolic diseases are intricately linked through bidirectional molecular mechanisms that foster a harmful cycle of physiological decline.This cycle is driven by several key factors,including altered nutrient sensing,mitochondrial dysfunction,cellular senescence,chronic inflammation,epigenetic modifications,circadian rhythm disruptions,and imbalances in the gut microbiota.Emerging interventions targeting this aging-metabolism axis hold significant promise for extending healthspan.These approaches include the use of pharmacological mi-metics,senolytics,multi-omics strategies,and microbiome modulation,all of which aim to restore metabolic homeostasis and mitigate age-related pathologies.However,several challenges remain in translating these strategies into clinical practice.These include the need for tissue-specific targeting,ensuring the long-term safety of interventions,and addressing socioeconomic disparities in healthcare ac-cess.Future research efforts are focusing on integrating multi-omic technologies,organoid and human cellular models,and developing equitable precision medicine frameworks.These initiatives aim to extend healthspan and reduce the global impact of aging-related metabolic diseases.
年,卷(期):
2025, (6)
机标分类号:
R285.5
S
R735.1
在线出版日期:
2026年3月3日